IFNA1 and COVID-19: Our study demonstrates the importance of longitudinal analysis of autoantibodies directed against type I IFNs, as we observed different patterns of anti-IFN autoantibody levels in individual COVID-19 patients over time, although the significance of this is currently unclear.